Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$231,143
-10.03%
Shares
Shares Volume: 8,393 Shares
Average Share Price: $27.54
INSIDER
Yale Catriona
Chief Development Officer (Officer)
reported on Sep 18 2024
traded on Sep 16 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 75,294 |
| PURCHASES/SALES 1Y | 0 / 8 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $218,497.49 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 2 / 40 |
| P/S VALUE RATIO | 0.228 |
| AVERAGE SALE VALUE | $402,992.78 |
| COMPANY PREVIOUS TRADES |